3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
5
Breast
5
Gastrointestinal
4
Tumor-Agnostic
3
Thoracic
3
Sarcoma
2
Dermatologic
2
Gynecologic
1
CNS
1
Conditions
Sarcoma
19
Neoplasms
7
Osteosarcoma
5
Gastrointestinal Stromal Tumors
4
Neuroblastoma
3
Melanoma
3
Uterine Cervical Neoplasms
2
Testicular Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Glioma
2
Esophageal Neoplasms
2
Desmoid Tumors
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Brain Neoplasms
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Somatostatinoma
1
Skin Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma, Ewing
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplastic Cells, Circulating
1
Interventions
pembrolizumab
11
Gemcitabine
10
Doxorubicin
10
Cyclophosphamide
9
Specimen Handling
8
Nivolumab
8
Ibandronic Acid
8
pazopanib
7
Radiosurgery
6
Magnetic Resonance Spectroscopy
6
Imatinib Mesylate
6
Biopsy
6
Bevacizumab
6
Irinotecan
5
regorafenib
4
Zoledronic Acid
4
Ipilimumab
4
Ifosfamide
4
Fluorouracil
4
Docetaxel
4
Cetuximab
4
sargramostim
3
conatumumab
3
cemiplimab
3
Sunitinib
3
Radiation
3
Paclitaxel
3
Leucovorin
3
Cryosurgery
3
Cisplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Blood Specimen Collection
×
Sarcoma
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled
NCT03375437
2024-08-26
RNASARC
Centre Leon Berard
Phase NA
Active not recruiting
376 enrolled